Pacira BioSciences (PCRX) Deferred Taxes (2020 - 2026)
Pacira BioSciences (PCRX) posted quarterly Deferred Taxes of $1.7 million for Q1 2026, up 23.84% year-over-year from $1.4 million in Q1 2025, and up 146.21% quarter-over-quarter from -$3.7 million in Q4 2025.
Pacira BioSciences (PCRX) Deferred Taxes (2020 - 2026) Analysis & Trends
Pacira BioSciences' Deferred Taxes history runs 7 years deep, the most recent figure standing at $1.7 million for Q1 2026.
- In Q1 2026, Deferred Taxes rose 23.84% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $6.8 million (down 63.3% YoY), while the FY2025 annual figure was $6.5 million, down 68.59% from the prior year.
- Deferred Taxes for Q1 2026 stood at $1.7 million, up from -$3.7 million in the prior quarter.
- The five-year high for Deferred Taxes was $12.5 million in Q2 2024, with the low at -$10.8 million in Q4 2022.
- The 5-year median for Deferred Taxes is $1.7 million (2026), against an average of $2.1 million.
- The sharpest annual moves came in 2023 and 2025: Deferred Taxes sank 25417.24% in 2023, then jumped 623.95% in 2025.
- Pacira BioSciences' Deferred Taxes stood at -$10.8 million in 2022, then soared by 160.89% to $6.6 million in 2023, then slumped by 46.86% to $3.5 million in 2024, then tumbled by 206.73% to -$3.7 million in 2025, then jumped by 146.21% to $1.7 million in 2026.
- Business Quant data shows PCRX's Deferred Taxes at $1.7 million in Q1 2026, -$3.7 million in Q4 2025, and $8.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 25.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -33.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 25.70 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -124.50 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -25.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Pacira BioSciences | 970.37 Mn | 719.34 Mn | 148.24 Mn | 3.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.91 Mn |
| Mar 31, 2026 | 1.73 Mn |
| Dec 31, 2025 | -3.74 Mn |
| Sep 30, 2025 | 8.07 Mn |
| Jun 30, 2025 | 752,000.00 |
| Mar 31, 2025 | 1.40 Mn |
| Dec 31, 2024 | 3.51 Mn |
| Sep 30, 2024 | 1.12 Mn |
| Jun 30, 2024 | 12.54 Mn |
| Mar 31, 2024 | 3.46 Mn |
| Dec 31, 2023 | 6.60 Mn |
| Sep 30, 2023 | 4.91 Mn |
| Jun 30, 2023 | 11.44 Mn |
| Mar 31, 2023 | -7.34 Mn |
| Dec 31, 2022 | -10.84 Mn |
| Sep 30, 2022 | 702,000.00 |
| Jun 30, 2022 | 2.16 Mn |
| Mar 31, 2022 | 29,000.00 |
| Dec 31, 2021 | -2.08 Mn |
| Sep 30, 2021 | 5.34 Mn |